EUS-Delivered therapy for pancreatic cancer:: Initial experience with targeted injection of 32P Biosilicon™

被引：3
|
作者：
Meenan, John
Mesenas, Steven
Douglas, Nivea
Heatley, Sarah
Doig, Laura
Ross, Paul
机构：
来源：
GASTROINTESTINAL ENDOSCOPY | 2007年 / 65卷 / 05期
关键词：
D O I：
10.1016/j.gie.2007.03.421
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：AB208 / AB208
页数：1
相关论文
共 50 条
  • [31] Multi-center, feasibility study on the use of EUS guided P32-labeled liquid based brachytherapy in advanced pancreatic cancer
    Mesenas, S.
    Meenan, J.
    Mahon, B.
    Chow, P. K.
    Foo, K. F.
    Goh, A.
    Heatley, S. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A141 - A141
  • [32] EUS GUIDED RADIOFREQUENCY ABLATION AS NEOADJUVANT THERAPY FOR RESECTABLE PANCREATIC CANCER: INITIAL RESULTS FROM A PROSPECTIVE PHASE II CLINICAL TRIAL (PANCARDINAL TRIAL)
    Joseph-Talreja, Mairin
    Rowe, Julie
    Cen, Putao
    Mayigegowda, Kavya Kelagere
    Bailey, Jennifer
    Patil, Prithvi
    Wray, Curtis
    Thosani, Nirav
    GASTROINTESTINAL ENDOSCOPY, 2023, 97 (06) : AB817 - AB817
  • [33] Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles
    Zhang, Hao
    Zhang, Wang
    Hu, Bochuan
    Qin, Xiaohua
    Yi, Tianxiang
    Ye, Yayi
    Huang, Xiaowan
    Song, Yang
    Yang, Zhenyu
    Qian, Jieying
    Zhang, Yunjiao
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
  • [34] EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy
    Lundy, Joanne
    Harris, Marion
    Zalcberg, John
    Zimet, Allan
    Goldstein, David
    Gebski, Val
    Borsaru, Adina
    Desmond, Christopher
    Swan, Michael
    Jenkins, Brendan J.
    Croagh, Daniel
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Precise pancreatic cancer therapy through targeted degradation of mutant p53 protein by cerium oxide nanoparticles
    Hao Zhang
    Wang Zhang
    Bochuan Hu
    Xiaohua Qin
    Tianxiang Yi
    Yayi Ye
    Xiaowan Huang
    Yang Song
    Zhenyu Yang
    Jieying Qian
    Yunjiao Zhang
    Journal of Nanobiotechnology, 21
  • [36] Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy
    Sasankan, Shenthol
    Rebuck, Lorraine
    Darrah, Gloria
    Turquie, Moises Harari
    Rabinowitz, Ian
    CASE REPORTS IN ONCOLOGY, 2020, 13 (03): : 1239 - 1243
  • [37] The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice
    Lee, I
    Lee, YH
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3139S - 3142S
  • [38] Overall Survival in Locally Advanced Pancreatic Cancer Patients Treated with a Biologic Using Endoscopic Ultrasound (EUS) FNI or CT-Guided Injection: A Single Institution Experience
    Chang, Kenneth J.
    Ashida, Reiko
    Muthusamy, Raman
    Imagawa, David K.
    Holcombe, Randall
    Sanati, Homayoon
    Zell, Jason A.
    Kuo, Jeffrey V.
    Blatner, Gretta L.
    Eubanks, Sentelle
    Lee, John G.
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB132 - AB133
  • [39] Identifying targetable pathways in pancreatic cancer from endoscopic ultrasound-guided fine-needle aspirates (EUS/FNA): Providing a personalized approach to targeted therapy
    Wang-Gillam, Andrea
    Wani, Sachin
    Langley, Emma J.
    Gao, Feng
    Murad, Faris
    Mullady, Daniel
    Early, Dayna S.
    Edmundowicz, Steven Alphonse
    Linehan, David
    Kuller, Anne
    Jain, Anjali
    Kim, Phillip Sangwook
    Singh, Sharat
    Azar, Riad
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [40] Detection of KRAS, BRAF, PIK3CA by microarray technology for targeted therapy in patients with pancreatic cancer: a single centre experience
    Petrusevska, G.
    Eftimov, A.
    Jovanovic, R.
    Krsteska, B.
    Janevska, V.
    VIRCHOWS ARCHIV, 2020, 477 : S145 - S146
12345